03.03.2026 02:01 | The Guardian World
Latest research based on animal model trials shows GLP-1 drugs may prevent problem of ‘no-reflow’ in recoveryWeight-loss drugs could help people who have had a heart attack avoid suffering potentially fatal complications afterwards, research has found.Drugs such as Ozempic and Wegovy reduce the risk of the tissue damage that affects up to half of the 100,000 people a year in the UK who suffer a heart attack, according to the study. Continue reading...
🔗 Citește articolul complet pe The Guardian World
18.10.2026 15:07 | Sport.ro
18.10.2026 15:04 | Sport.ro
18.10.2026 15:02 | Ziarul Financiar
18.10.2026 15:00 | Economica.net
18.10.2026 15:00 | The Guardian World
18.10.2026 15:00 | The Guardian World